期刊文献+

祛异康对子宫内膜异位症大鼠腹腔液IL-2、IL-6的影响 被引量:1

Effect of Qu Yi Kang on the Celiac Liquid IL-2 and IL-6 of Endometriosis Rats
下载PDF
导出
摘要 目的:观察中药祛异康对子宫内膜异位症大鼠腹腔液IL-2、IL-6的影响,探讨其治疗子宫内膜异位症的机理。方法:将40只健康雌性SD大鼠随机分为4组:A组只行开关腹,B、C、D组均行内膜移植,造模完成后,A、B组以生理盐水灌胃,C、D组分别给予中药祛异康、西药丹那唑灌胃,4周后开腹收集腹腔液测定IL-2I、L-6表达水平。结果:祛异康可以降低异位症大鼠腹腔液中IL-2及IL-6浓度(P<0.05;P<0.01)。结论:祛异康能明显改善腹腔微环境,其治疗子宫内膜异位症的作用机理可能是通过改变腹腔液微环境,降低细胞因子IL-2、IL-6的水平,从而抑制异位内膜生长来实现的。 Objective: To observe the effect of Qu Yi Kang on the celiac liquid IL-2 and IL-6 of endometriosis rats and explore its treatment mechanism.Methods: 40 healthy female rats were divided into 4 groups.Group A was given an open-and-close abdominal operation.Group B,C and D were equally given intimal transplants.After the models were made,group A and B were infused with normal salt solution while group C and D were infused with Qu Yi Kang(traditional Chinese medicine) and Dan Na Chuo(western medicine).After 4 weeks,the collection of celiac liquid by the open-and-close abdominal operation was determined to the level of IL-2 and IL-6.Results: Qu Yi Kang could decease the density of IL-2 and IL-6 of the endometriosis rats(P<0.05;P>0.01).Conclusion: Qu Yi Kang can obviously improve the abdominal microcirculation and its treatment mechanism may probably operate by decreasing the level of IL-2 and IL-6 cell agent to inhibit the production of the endometriosis.
作者 杨鉴冰 徐翠
出处 《云南中医中药杂志》 2007年第10期36-37,共2页 Yunnan Journal of Traditional Chinese Medicine and Materia Medica
基金 陕西省教育厅自然科学资助项目(编号:2007JK236)
关键词 子宫内膜异位症 大鼠模型 IL-2 IL-6 中药祛异康 实验研究 endometriosis rat model IL-2 IL-6 Qu Yi Kang experiment
  • 相关文献

参考文献8

二级参考文献24

  • 1黄邱朝,刘琦.子宫内膜异位症不孕患者的免疫学分析与临床意义[J].实用妇产科杂志,1993,9(6):305-306. 被引量:7
  • 2王红蓓,孔宪涛,张玲珍,潘郁婴.硫酸软骨素A对正常人及慢性乙肝患者NK、ADCC活性影响的体外实验[J].中国免疫学杂志,1993,9(6):361-364. 被引量:9
  • 3[1]乐杰,主编.妇产科学.第五版.北京:人民卫生出版社,2001. 387 - 395
  • 4[2]Cheong YC,Shelton JB,Laird SM,et al.IL-1,IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions.Hum Reprod,2002,17: 69-75.
  • 5[4]Sahakian V,Anners J,Haskill S,et al. Selective localization of interlenkin-1 receptor antagonist in eutopic endometrium and endometriotic implants.Fertil Steril,1993,60:276-279.
  • 6[5]Arici A.Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis.Ann N Y Acad Sci,2002,955:101-109.
  • 7[6]Mulayim N,Savlu A,Guzeloglu-Kayisli O,et al. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8.Fertil Steril,2004,81(Suppl 1):904-911.
  • 8[7]Arici A,Matalliotakis I,Goumenou A,et al.Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion.Hum Reprod,2003,18: 429-432.
  • 9[8]Li XF,Charnock-Jones DS,Zhang E,et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells.J Clin Endocrinol Metab,2001,86: 1823-1834.
  • 10[9]Oku H,Tsuji Y,Kashiwamura SI,et al.Role of IL-18 in pathogenesis of endometriosis.Hum Reprod,2004,19: 709-714.

共引文献150

同被引文献6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部